NCT00187122 - Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 1993

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions

Lymphoblastic Lymphoma

Interventions

DRUG

Vincristine

See Detailed Description section for description of treatment plan.

PROCEDURE

Radiation Therapy

See Detailed Description section for description of treatment plan.

DRUG

Daunomycin

See Detailed Description section for description of treatment plan.

DRUG

L-Asparaginase

See Detailed Description section for description of treatment plan.

DRUG

Cytarabine

See Detailed Description section for description of treatment plan.

DRUG

Methotrexate

See Detailed Description section for description of treatment plan.

DRUG

Mercaptopurine

See Detailed Description section for description of treatment plan.

DRUG

Etoposide

See Detailed Description section for description of treatment plan.

DRUG

Cyclophosphamide

See Detailed Description section for description of treatment plan.

DRUG

Prednisone

See Detailed Description section for description of treatment plan.

DRUG

Dexamethasone

See Detailed Description section for description of treatment plan.

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors

lead

St. Jude Children's Research Hospital

OTHER